IMPL
Income statement / Annual
Last year (2022), Impel Pharmaceuticals Inc.'s total revenue was $12.65 M,
an increase of 1,794.01% from the previous year.
In 2022, Impel Pharmaceuticals Inc.'s net income was -$129.44 M.
See Impel Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$12.65 M |
$668,000.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$6.50 M
|
$691,000.00
|
$0.00
|
$0.00
|
| Gross Profit |
$6.16 M
|
-$23,000.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.49
|
-0.03
|
0
|
0
|
| Research and Development Expenses |
$11.46 M
|
$20.56 M
|
$27.29 M
|
$28.81 M
|
| General & Administrative Expenses |
$77.89 M
|
$50.90 M
|
$18.05 M
|
$12.75 M
|
| Selling & Marketing Expenses |
$7.60 M
|
$12.60 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$77.89 M
|
$50.90 M
|
$18.05 M
|
$12.75 M
|
| Other Expenses |
-$9.29 M
|
-$5.05 M
|
-$408,000.00
|
-$680,000.00
|
| Operating Expenses |
$89.34 M
|
$71.46 M
|
$45.33 M
|
$41.57 M
|
| Cost And Expenses |
$95.84 M
|
$72.15 M
|
$45.33 M
|
$41.57 M
|
| Interest Income |
$10.58 M
|
$2.25 M
|
$0.00
|
$417,000.00
|
| Interest Expense |
$13.84 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.20 M
|
$1.09 M
|
$1.08 M
|
$722,000.00
|
| EBITDA |
-$83.18 M |
-$70.40 M |
-$44.26 M |
-$40.84 M |
| EBITDA Ratio |
-6.57
|
-107.01
|
0
|
0
|
| Operating Income Ratio |
-6.57
|
-107.01
|
0
|
0
|
| Total Other Income/Expenses Net |
-$23.13 M
|
-$5.05 M
|
-$463,000.00
|
-$263,000.00
|
| Income Before Tax |
-$106.31 M
|
-$76.53 M
|
-$45.80 M
|
-$41.83 M
|
| Income Before Tax Ratio |
-8.4
|
-114.57
|
0
|
0
|
| Income Tax Expense |
$23.13 M
|
$2,000.00
|
$1,000.00
|
$30,000.00
|
| Net Income |
-$129.44 M
|
-$76.54 M
|
-$45.80 M
|
-$41.86 M
|
| Net Income Ratio |
-10.23
|
-114.57
|
0
|
0
|
| EPS |
-5.52 |
-5.24 |
-3.49 |
-3.19 |
| EPS Diluted |
-5.52 |
-5.24 |
-3.49 |
-3.19 |
| Weighted Average Shares Out |
$23.45 M
|
$14.60 M
|
$13.14 M
|
$13.14 M
|
| Weighted Average Shares Out Diluted |
$23.45 M
|
$14.60 M
|
$13.14 M
|
$13.14 M
|
| Link |
|
|
|
|
